Identification of CYP 21 A 2 mutant alleles in Czech patients with 21-hydroxylase deficiency

[1]  V. Toscano,et al.  A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form , 2009, BMC Medical Genetics.

[2]  J. Gonçalves,et al.  Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency , 2007, Expert Reviews in Molecular Medicine.

[3]  Maria I New,et al.  Extensive clinical experience: nonclassical 21-hydroxylase deficiency. , 2006, The Journal of clinical endocrinology and metabolism.

[4]  B. Persson,et al.  Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia. , 2006, Molecular endocrinology.

[5]  F. Waldhauser,et al.  Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria , 2006, European Journal of Pediatrics.

[6]  A. T. Rêgo,et al.  CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. , 2006, Molecular genetics and metabolism.

[7]  J. Costas,et al.  High variability in CYP21A2 mutated alleles in Spanish 21‐hydroxylase deficiency patients, six novel mutations and a founder effect , 2006, Clinical endocrinology.

[8]  T. Battelino,et al.  Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. , 2005, European journal of endocrinology.

[9]  J. Popović,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2005, Journal for specialists in pediatric nursing : JSPN.

[10]  B. Mendonca,et al.  Substitutions in the CYP21A2 promoter explain the simple‐virilizing form of 21‐hydroxylase deficiency in patients harbouring a P30L mutation , 2005, Clinical endocrinology.

[11]  Yann-Jinn Lee,et al.  PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. , 2004, Genomics.

[12]  L. Hoefsloot,et al.  CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. , 2003, The Journal of clinical endocrinology and metabolism.

[13]  T. Hoogenboezem,et al.  Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions. , 2002, Human molecular genetics.

[14]  T. Hoogenboezem,et al.  Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes , 2002, Human Genetics.

[15]  F. Waldhauser,et al.  Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  O. Hiort,et al.  The Molecular Basis of Androgen Insensitivity , 2001, Hormone Research in Paediatrics.

[17]  G. Heinze,et al.  Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. , 2001, The Journal of clinical endocrinology and metabolism.

[18]  A. Grüters,et al.  How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. , 2000, The Journal of clinical endocrinology and metabolism.

[19]  H. Chao,et al.  Analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency. , 2000, Clinical chemistry.

[20]  A. Braun,et al.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. , 2000, The Journal of clinical endocrinology and metabolism.

[21]  M. New,et al.  Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. R. Welch,et al.  Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module) , 1999, The Journal of Biological Chemistry.

[23]  B. Chung,et al.  Difference in transcriptional activity of two homologous CYP21A genes. , 1995, Molecular endocrinology.

[24]  S. Gitelman,et al.  Abundant adrenal-specific transcription of the human P450c21A "pseudogene". , 1993, The Journal of biological chemistry.

[25]  H. Luthman,et al.  Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. , 1993, Human molecular genetics.

[26]  M. Waterman,et al.  Evidence that an adrenal-specific nuclear protein regulates the cAMP responsiveness of the human CYP21B (P450C21) gene. , 1991, The Journal of biological chemistry.

[27]  M. Waterman,et al.  cAMP-dependent transcription of the human CYP21B (P-450C21) gene requires a cis-regulatory element distinct from the consensus cAMP-regulatory element. , 1990, The Journal of biological chemistry.

[28]  O. Gotoh,et al.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Strominger,et al.  Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Hsien-Hsiung Lee.  Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. , 2005, Molecular genetics and metabolism.